ArticleCureus2025
Fulminant Eosinophilic Myocarditis in a Young Adult: Successful Recovery After Extracorporeal Membrane Oxygenation (ECMO) Support and Multisystem Complications.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic myocarditis (EM) is a rare inflammatory cardiomyopathy with a highly variable clinical presentation, ranging from mild symptoms to fulminant cardiogenic shock. Its diagnosis is challenging due to non-specific clinical findings and requires a high index of suspicion, with endomyocardial biopsy (EMB) serving as the gold standard. Early initiation of immunosuppressive therapy and, in severe cases, mechanical circulatory support (MCS) are essential to improve outcomes. We report the case of a 21-year-old male who presented with progressive dyspnea, chest pain, and hypoxemia. Echocardiography revealed severe left ventricular dysfunction. Coronary angiography excluded obstructive disease, while EMB confirmed EM. Due to cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (ECMO) was implanted on the day of admission. High-dose corticosteroids and azathioprine were initiated, leading to gradual improvement of ventricular function and subsequent ECMO explantation. The course was complicated by left ventricular thrombus formation, which resolved under systemic anticoagulation, and by ischemic colitis requiring right hemicolectomy with ileostomy. Following tracheostomy and prolonged weaning, the patient achieved functional recovery and was discharged on immunosuppressive and anticoagulant therapy. Six months later, surgical restoration of bowel continuity was performed without complications. Follow-up echocardiography demonstrated recovery of left ventricular ejection fraction (LVEF) to 50%, with no evidence of thrombus recurrence. This case highlights the diagnostic and therapeutic challenges of EM, including its fulminant presentation, life-threatening complications, and the critical role of multidisciplinary management. Prompt recognition, biopsy-guided diagnosis, early immunosuppression, MCS when indicated, and careful monitoring for systemic complications can lead to favorable outcomes, even in complex and prolonged clinical courses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.